News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  30th July 2012  
  IMCB welcomes Principal Investigator Jonathan Loh
 
 



IMCB welcomes Principal Investigator Jonathan Loh.

IMCB extends a warm welcome to Dr Jonathan Yuin-Han Loh who joins IMCB from August 1, 2012 as Principal Investigator.

Jonathan received his B.Sc. in Cellular and Molecular Biology with 1st Class Honours from the National University of Singapore (2003). He did his Ph.D. research (2003-2007) in the laboratory of Dr Ng Huck-Hui at the Genome Institute of Singapore, where he elucidated the link between the genetic and epigenetic regulation mechanisms controlling ES cells. This resulted in the discovery of novel transcription factors and chromatin modifiers that are necessary in determining the ES cell fate. He completed his Postdoctoral Fellowship (2008-2011) with Professor George Q. Daley at the Howard Hughes Medical Institute in the Children’s Hospital Boston, Harvard Medical School. There, he focused on developing innovative technologies to engineer defined factor cell fate reprogramming. Jonathan’s work has shown that terminally differentiated human blood cells can be epigenetically reprogrammed to pluripotent stem cells. He returned to Singapore to join the Institute of Medical Biology (2011-2012) as Principal Investigator and the NUS Department of Biological Sciences as an Adjunct Assistant Professor (2011). His laboratory is interested in dissecting the genetic and epigenetic mechanisms regulating cell fate changes, while developing novel tools and strategies in deriving differentiated cell types via defined factors reprogramming. Jonathan has published extensively in top international journals and his articles have been cited over 3500 times. He is a recipient of several awards including the Quest Technology award (1997), Hong Kong and Shanghai Banking Corporation scholarship (2002), A*STAR Graduate Scholarship (2003-2011), Philip Yeo Prize (2008), Singapore Young Scientist Award (2009), Singapore Youth Award (2010), A*STAR Investigatorship Research Award (2011) and the MIT TR35 (Asia Pacific)@Singapore Award (2012). 

 

We welcome Dr Jonathan Loh and his laboratory to IMCB.

For more information on Jonathan's laboratory, please click here.